Strados Labs, founded with the mission to advance respiratory health management, specializes in developing clinical-grade biosensors and intelligent software. Their core products include FDA-cleared lung acoustic biomarkers that provide real-world, objective insights into patient respiratory health, focusing on symptoms such as cough and wheeze. Strados Labs serves a diverse market including hospitals, health systems, skilled nursing facilities, the pharmaceutical industry, physicians, and payers.
Notable affiliations include partnerships with healthcare providers and pharmaceutical companies, leveraging their technology for clinical trials and real-world monitoring. Key achievements include FDA clearance for their biosensor technology and successful integration into various healthcare settings. Strados Labs has significantly impacted respiratory health management by providing precise, real-time data that enhances patient care and treatment outcomes.
